26 MEDICAL CONSULTANCY LIMITED
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £77.0k | £47.2k |
| Current assets | £84.6k | £55.6k |
| Net assets | £76.1k | £45.6k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
Corporate timeline (6 events)Click to expand
- 2025-11-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-08-15📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-03-28🏢Company incorporatedAs 26 MEDICAL CONSULTANCY LIMITED
- 2022-03-28➕AHMAD, Uzma, Dr appointeddirector
- 2022-03-28📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Uzma Ahmad Individual · British · DOB 07/1970 · age 56 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 28/03/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · B postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 7SVASS B LTD→ 14846065 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| A BETTER YOU SB LTD→ 15554761 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AA DERM LTD→ 16154966 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AA OPHTHALMIC SERVICES LTD→ 10266999 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AA SKIN FORMULATIONS LTD→ 14561524 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AA SUTTON DIAGNOSTICS LIMITED→ 12639177 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AA3 CARE SOLUTIONS LIMITED→ 13991635 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AAD RADIOLOGY LTD→ 14308606 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AAP DENT LIMITED→ 16100022 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AAP ENTERPRISES LTD→ 10941324 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AARAV HEALTHCARE PVT LTD→ 12726615 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AARJ CARE SERVICES LTD→ 15419626 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.